Naloxegol Approval Status
- FDA approved: No
- Generic name: naloxegol
- Company: AstraZeneca
- Treatment for: Constipation
Naloxegol is a peripherally-acting mu-opioid receptor antagonist being investigated for the treatment of constipation as a side effect of prescription opioid pain medicines.
FDA Approval Status for naloxegol
|Nov 19, 2013||New Drug Application for Naloxegol Accepted by United States Food and Drug Administration|
|Feb 26, 2013||AstraZeneca Announces Results From Long-Term Safety Trial Of Naloxegol In Patients With Opioid-Induced Constipation|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.